Rani Therapeutics Holdings, Inc. (RANI)
NGM – Real Time Price. Currency in USD
0.74
-0.01 (-0.86%)
At close: Jun 26, 2026, 4:00 PM EDT
0.73
-0.00 (-0.12%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
0.74
-0.01 (-0.86%)
At close: Jun 26, 2026, 4:00 PM EDT
0.73
-0.00 (-0.12%)
After-hours: Jun 26, 2026, 7:52 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $9.8M significantly exceed its total debt $3.9M, ensuring strong financial flexibility
Total current assets $47.1M exceed Total current liabilities $13.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-94.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$6.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.40 | 6.05 | 10 | |
| Quick ratio | 3.40 | 5.63 | 10 | |
| Debt to Equity | 0.14 | 0.30 | 9.0 | |
| Debt to Assets | 0.08 | 1.04 | 9.0 | |
| Interest coverage | -94.76 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 1M | 2M | 3M |
| Gross Profit | -1M | -822K | N/A | 733K | 2M |
| Operating Income | -63M | -66M | -50M | -38M | -35M |
| Net Income | -31M | -34M | -30M | -30M | -29M |
| EBITDA | -62M | -65M | -49M | -37M | -34M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 70.83 | 5.5 |
| Next quarter | N/A | 56.25 | 5.5 |
| Current year | 152.6 | 57.22 | 10 |
| Next year | 19.39 | -11.69 | 5.0 |
| Weighted average score | 6.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 16.91 | 31.76 | 42.86 | -2314.96 | 7.5 |
| Y/Y | 893.02 | 3.18 | 81.82 | 20.59 | 8.5 |
| 3y average | 685.62 | 0.58 | 24.76 | 23.42 | 8.0 |
| 5y average | 488.99 | -43.05 | -30.83 | -15.86 | 3.3 |
| Weighted average score | 6.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |